In vivo rates of incorporation and turnover of palmitate and arachidon
ate in brain phospholipids were measured in awake rats treated chronic
ally with lithium, following intravenous infusion of radiolabeled palm
itate and arachidonate, respectively. Chronic lithium, at a brain leve
l considered to be therapeutic in humans, decreased turnover of arachi
donate within brain phosphatidylinositol, phosphatidylcholine and phos
phatidylethanolamine by up to 80% (P < 0.001). In contrast, lithium ha
d a minimal effect on turnover of palmitate, causing only a 26% reduct
ion in turnover in phosphatidylcholine (P < 0.01). These results sugge
st that a major therapeutic effect of lithium is to reduce turnover sp
ecifically of arachidonate, possibly by inhibiting phospholipase A(2)
involved in signal transduction. The effect may be secondary to the kn
own action of lithium on the phosphoinositide cycle, by inhibiting the
activity of inositol monophosphatase. (C) 1996 Elsevier Science Irela
nd Ltd.